
Delegate Resources
These resources are for ESM Congress delegates only.
Please do not share.
Abstracts
OR01
Molecular Biology and Mycobacterial Evolution
Molecular Epidemiology of Tuberculosis in Ukraine: A Nationwide Whole-Genome Sequencing Study (2020–2023)
Dmytro Butov, Department of Infectious Diseases, Children's Infectious Diseases and Phthisiology, Kharkiv National Medical University, Kharkiv, Ukraine
OR05
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
Standardised protocol for the detection and quantification of nontuberculous mycobacteria in tap water and its application in investigating the source of clinical infections
Camille Allam, Centre National de Référence des Mycobactéries et de la Résistance aux Antituberculeux (CNR MyrMA)
OR17
Recent advances in research on Mycobacterial pathogenesis
When Non-Pathogens Kill: Mycolicibacterium manresensis as a Model for Cryptic Virulence in Mycobacteria
Mariona Cortacans, Unitat de Tuberculosi Experimental. Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP), Badalona (08916), Catalonia, Spain
OR19
New generation vaccines for TB
Evaluation of immune responses elicited by respiratory mucosal vaccination strategies against TB in a goat model
Patricia Cuenca Lara, Programa de Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), IRTA, Campus de la Universitat Autònoma de Barcelona, Bellaterra, 08193, Catalonia, Spain.
OR31
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
Natural drivers and Human-Induced Pressures shaping the distribution of Mycobacterium ulcerans and Buruli Ulcer
Alisa Aliaga Samanez, 1. MIVEGEC (UMR Université de Montpellier, CNRS, IRD), Montpellier, France.
OR33
Systems Biology Approaches to Accelerate Mycobacteriosis Drug Discovery
Implementing large-scale genomics and genomic subtractive strategies to expand the target space in Mycobacterium tuberculosis: a strategy for improving target-based drug discovery
P Gomes, Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Lisboa, Portugal
OR34
Systems Biology Approaches to Accelerate Mycobacteriosis Drug Discovery
Exploring in silico drug repurposing to develop new therapeutic alternatives for tuberculosis
Liliana Rodrigues, Global Health and Tropical Medicine, GHTM, LA-REAL, Instituto de Higiene e Medicina Tropical, IHMT, Universidade NOVA de Lisboa, UNL, Lisboa, 1349-008, Portugal
P006
Clinical pathology and diagnostic advances
Diagnostic capacity and Biosafety practices for Tuberculosis: Assessment of the Portuguese National Laboratory Network
Ana Rita Macedo, National Reference Laboratory for Mycobacteria, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge, Portugal
P012
Clinical pathology and diagnostic advances
Detection of first-line and second-line Drug-Resistance mediating mutations in Mycobacterium tuberculosis with FluoroLyse and GenoXtract fleXT extracted DNA from sputum Using Next-Generation Sequencing
V Allerheiligen, Hain Lifescience GmbH - A Bruker company
P015
Clinical pathology and diagnostic advances
Overcoming barriers for non-tuberculous Mycobacteria identification: application of a culture-independent targeted sequencing approach
Ana Rita Macedo, National Reference Laboratory for Mycobacteria, Department of Infectious Diseases, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal
P023
Molecular Biology and Mycobacterial Evolution
Genetic characterisation of Mycobacterium bovis strains isolated from cattle in Northern Africa
Isabel Dickie, The Royal Veterinary College
P031
Clinical pathology and diagnostic advances
Rapid drug resistance prediction in positive Mycobacterium tuberculosis clinical samples using an extensive targeted next-generation sequencing panel
Rita Macedo, National Reference Laboratory for Mycobacteria, Infectious Diseases Department, National Institute of Health Doctor Ricardo Jorge
P037
Host-Pathogen interactions in TB
Exploring patterns of serum CRP level reduction in response to treatment initiation in Latvian patients with pulmonary tuberculosis: the impact of Mycobacterium tuberculosis genotype
Agnija Kivrane, Pharmacogenetic and Precision Medicine Laboratory, Pharmaceutical Education and Research Centre, Riga Stradins University, Konsula Street 21, LV1007 Riga, Latvia
P039
Host-Pathogen interactions in TB
Chitosan-particle-based cystatin F RNA silencing as a therapeutic strategy to improve the control of intracellular Mycobacterium tuberculosis
Manoj Mandal, Host-Pathogen Interactions Unit, Research Institute for Medicines, Faculty of Pharmacy, University of Lisbon, Portugal
P045
Host-Pathogen interactions in TB
Phagocytosis of Mycobacterium fortuitum by caprine alveolar macrophages is associated with iNOS and proinflammatory marker expression
Miriam Blay Benach, Programa de Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), IRTA, Campus de la Universitat Autònoma de Barcelona, Bellaterra, 08193, Catalonia, Spain.
P065
Molecular Biology and Mycobacterial Evolution
Unexpected diversity in long-term infections by non-tuberculous mycobacteria revealed by longitudinal genomic analysis
Laura Pérez, Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, España
P069
Molecular Biology and Mycobacterial Evolution
An alternative for high-throughput Illumina-based sequencing: Individualized nanopore analysis of new incident cases coupled to targeted sequencing
S M Saleeb, Department of Clinical Microbiology and Infectious Diseases, Gregorio Marañón General University Hospital, Madrid, Spain
P070
Molecular Biology and Mycobacterial Evolution
An extended genomic analysis reveals unexpected transmissions involving the pediatric population in Madrid with tuberculosis
Marta López Llaría, Servicio de Microbiología clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, 28009, España
P073
Molecular Biology and Mycobacterial Evolution
Genomic insights into Mycobacterium avium complex isolates from Portugal reveal extensive genetic diversity
Miguel Pinto, Genomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal
P085
Molecular Biology and Mycobacterial Evolution
Deciphering NucS interactions to explore anti-evolution strategies against Mycobacterium tuberculosis
Rima Zein Eddine, Laboratoire d'Optique et Biosciences (LOB), Ecole Polytechnique, Inserm U1182, CNRS UMR7645, Institut Polytechnique de Paris, 91120 Palaiseau, France.
P097
Neglected mycobacterial diseases
Mycobacterium appelbergii sp. nov., a novel species isolated from a drinking water fountain in a rural community
Susana Alarico, CNC-UC - Center for Neuroscience and Cell Biology and CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Portugal
P101
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
Detected cases of Mycobacterium tuberculosis infection in domestic and companion animals – indicators of epidemiological trends and health risks
Silvio Špicic, National Reference Laboratory for Animal Tuberculosis, Department for Bacteriology and Parasitology, Croatian Veterinary Institute, Zagreb, Croatia
P102
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
GenEpi-BioTrain: Interdisciplinary training in genomic epidemiology and public health bioinformatics: 5th edition (tuberculosis focus)
Ivan Barilar, Research Center Borstel Leibniz Lung Center
P104
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
Linking long-term and short-term Mycobacterium tuberculosis transmission dynamics inferred form 15 years study in Orizaba, Mexico
Paula Sinisterra Sebastián, Tuberculosis Genomics Unit, Instituto de Biomedicina de Valencia, CSIC, Valencia, 46011 Spain
P105
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
Tuberculosis Alert: a board game designed to promote tuberculosis awareness and fight stigma
Pablo Soldevilla, Unitat de Tuberculosi Experimental, Microbiology Dept. Germans Trias i Pujol Research Institute and Hospital (IGTP-HUGTIP), Badalona, 08916, Spain
P106
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
Genomic Analysis of Mycobacterium chelonae isolates associated with heater-cooler units: a potential risk of infection during cardiac surgery
Simone Mok, Irish Mycobacteria Reference Laboratory, St. James’s Hospital, Dublin, Ireland
P107
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
Applications and challenges of prospective whole genome sequencing for tuberculosis public health investigations: a systematic review.
Daisy Wang, Australian National University National Center for Epidemiology and Population Health
P109
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
The impact, implementation, and ethics of whole genome sequencing for tuberculosis public health: staff perspectives from an outbreak in Victoria, Australia
Daisy Wang, National Center for Epidemiology and Population Health, Australian National University
P110
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
‘I was in a place where I was going to be healed. Let others think what they want’: A qualitative study on the experience of having tuberculosis in a sample of the Portuguese population
P Barbosa, EPIUnit ITR, Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal
P111
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
A multinational Delphi consensus on TB screening of migrants in Europe
A Aguiar, EPIUnit ITR, Instituto de Saúde Pública da Universidade do Porto, Universidade do Porto, Rua das Taipas, n° 135, 4050-600 Porto, Portugal
P113
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
Genomic Surveillance Uncovers Ongoing Tuberculosis Transmission in Catalonia (2022–2024).
Pere-Joan Cardona, Servei de Microbiologia, Laboratori Clínic Metropolitana Nord. Institut de Recerca i Hospital Germans Trias i Pujol (IGTP) – Badalona, Barcelona
P114
Systems Biology Approaches to Accelerate Mycobacteriosis Drug Discovery
Exploring LL-37-Based Synthetic Peptides to combat Multidrug-Resistant Tuberculosis: A step toward innovative therapies.
Paola Santos, Grupo Relaciones Microbianas y Epidemiológicas Aplicadas al Laboratorio Clínico y Molecular (REMA), Facultad de Ciencias de la Salud, Universidad Colegio Mayor de Cundinamarca, Bogotá, 110311, Colombia.
P115
Systems Biology Approaches to Accelerate Mycobacteriosis Drug Discovery
Validation of a cost-effective Drosophila melanogaster platform to identify novel treatments against tuberculosis
Maria Vidal Ramos, Unitat de Tuberculosi Experimental, Microbiology Dept. Germans Trias i Pujol Research Institute and Hospital (IGTP-HUGTIP), Badalona, 08916, Spain
